NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Scarlet Therapeutics

Scarlet Therapeutics

Private
BristolHealthcare & Life Scienceshttps://scarlet-tx.com/

Last Round

Seed

May 7, 2026

Total Funding Raised

$4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Scarlet Therapeutics is a biotechnology company developing a platform for generating therapeutic red blood cell (tRBC) therapies to treat rare metabolic diseases, cancer, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic red blood cellstRBCscell therapyimmortalized cell linesengineered cell therapyrare metabolic diseasesoff-the-shelf therapytherapeutic protein deliverydrug delivery platformlab-grown bloodsynthetic biologydonor-independentuniversal blood productspre-clinical biotechplatform licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scarlet Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Scarlet Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scarlet Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 7, 2026
Pre SeedMay 23, 2023

Key People

Founding team and executive leadership

Alistair Irvine

Chief Executive Officer

Executive Team

Scarlet Therapeutics Investors

Notable investors and investment history

Scarlet Therapeutics investors
InvestorRounds
Oshen Holdings SASeed
SCVCSeed
Meltwind AdvisoryPre Seed
Daft CapitalSeed
Science Creates VenturesSeed, Pre Seed
Eos AdvisorySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 7, 2026

    $4M round led by Eos Advisory.

  • Nov 9, 2025

    Monthly visitors grew 108% MoM.

Scarlet Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scarlet Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scarlet Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol
Employee Range15
Year Founded2022
Last FundingMay 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.